Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies

NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

New Biomarker for Alzheimer's Disease Diagnostic

NCT01315639 ·Status: COMPLETED ·Phase: NA

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

NCT05245903 ·Status: RECRUITING

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

NCT07099001 ·Status: COMPLETED ·Phase: NA

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

NCT02021682 ·Status: COMPLETED

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

NCT01000870 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease

NCT02409030 ·Status: COMPLETED

The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy

NCT04309253 ·Status: RECRUITING ·Phase: PHASE2

Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

NCT07222280 ·Status: RECRUITING ·Phase: NA

Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants

NCT02792179 ·Status: COMPLETED ·Phase: PHASE1

Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients

NCT06079827 ·Status: RECRUITING

Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

NCT03136679 ·Status: COMPLETED

The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease

NCT07680335 ·Status: RECRUITING ·Phase: NA

Study to Evaluate Amyloid in Blood and Imaging Related to Dementia

NCT03899844 ·Status: COMPLETED

In Vivo Alzheimer Proteomics

NCT02263235 ·Status: TERMINATED ·Phase: NA

A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease

NCT05326009 ·Status: UNKNOWN

DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease

NCT05844488 ·Status: COMPLETED

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

NCT04566003 ·Status: COMPLETED ·Phase: PHASE1

Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

NCT03089827 ·Status: ENROLLING_BY_INVITATION

A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

NCT01397578 ·Status: COMPLETED ·Phase: PHASE2

Study on Novel Peripheral Blood Diagnostic Biomarkers for MCI Due to Alzheimer's Disease

NCT04509271 ·Status: UNKNOWN

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

NCT01028053 ·Status: COMPLETED ·Phase: PHASE3

Quality Improvement PrecivityAD Clinician Survey (QUIP I)

NCT05477056 ·Status: COMPLETED

Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression

NCT07717567 ·Status: RECRUITING

Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease

NCT03977584 ·Status: COMPLETED ·Phase: PHASE2